QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Involve stakeholders and think “Nordic”
In this text, Mary Rosenzweig, Country director Denmark at Quantify Research, gives her perspectives on the changing landscapes in market access and real-world evidence in Denmark and the keys to successful value demonstration of new innovative medicines.
Involve stakeholders and think “Nordic”
Personally, I believe that if we want to support the innovation of new treatments to patients with high need, involvement from all different stakeholders will be necessary: Patients, clinicians, […]
Real-world evidence can reduce uncertainty and improve patient access
In this text, Mary Rosenzweig, Country director Denmark at Quantify Research, gives her perspectives on the changing landscapes in market access and real-world evidence in Denmark and the keys to successful value demonstration of new innovative medicines.
Real-world evidence can reduce uncertainty and improve patient access
The Danish Medicines Council has been exploring new approaches to market access including managed entry agreements. One approach is where a new treatment is offered […]
20th October: World Osteoporosis Day
Today, October 20th, is World Osteoporosis Day. Organized by the International Osteoporosis Foundation, the day is marked annually to raise awareness of bone health and osteoporosis prevention, this year calling for global action to fight the disease and related fractures worldwide
Quantify Research has a strong research record in the field of osteoporosis, having led a large number of international research projects leading to numerous scientific publications. Most recently, Quantify’s Jonas […]
Innovative medicines require an innovative approach
In this text, Mary Rosenzweig, Country director Denmark at Quantify Research, gives her perspectives on the changing landscapes in market access and real-world evidence in Denmark and the keys to successful value demonstration of new innovative medicines.
Innovative medicines require an innovative approach
As the costs of healthcare rise globally, Denmark is working hard to keep healthcare spending under tight control in unison with payers everywhere. Hence, great attention is given […]